Human uterine epithelial cell secretions regulate dendritic cell differentiation and responses to TLR ligands.
The balance between immunity and tolerance in the endometrium is governed by dynamic interactions of UEC and immune cells including DC. In this study, we tested the hypothesis that soluble immune mediators secreted by UEC modulate the differentiation and functions of human DC. We found that DC differentiated with CM from polarized UEC (i.e., CM-DC) expressed significantly lower surface CD86. Upon activation with LPS or PIC, the expression of CD80, CD86, and CD83 was decreased significantly on CM-DC relative to Con-DC. Further, mRNA for TLR3, TLR4, and TLR5 was decreased significantly in CM-DC relative to Con-DC. As a functional read-out of the effect of CM on DC, we determined the following parameters: First, analysis of cytokine production showed that when compared with Con-DC, CM-DC responded to LPS or PIC stimulation with enhanced IL-10 production but undetectable IL-12p70 secretion. Second, RT-PCR analysis showed that CM-DC significantly expressed higher mRNA for IDO, an immune tolerance-promoting enzyme. Lastly, in a MLR assay, CM-DC induced significantly lower allogeneic proliferative responses compared with Con-DC. These findings indicate collectively that epithelial cells confer a tolerogenic phenotype to DC in the endometrium. Our results suggest novel cellular and molecular mechanisms for the regulation of adaptive immunity within the FRT.
Ochiel
Daniel O
DO
Department of Physiology, Dartmouth Medical School, One Medical Center Drive, Lebanon, NH 03756, USA.
Ghosh
Mimi
M
Fahey
John V
JV
Guyre
Paul M
PM
Wira
Charles R
CR
D000328:Adult; D002454:Cell Differentiation / Q000187:drug effects / Q000276:immunology*; D002460:Cell Line; D049109:Cell Proliferation / Q000187:drug effects; D017077:Culture Media, Conditioned / Q000494:pharmacology; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000166:cytology* / Q000201:enzymology / Q000276:immunology* / Q000378:metabolism; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000235:genetics / Q000378:metabolism; D008024:Ligands; D008297:Male; D009000:Monocytes / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051193:Toll-Like Receptors / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D053773:Transforming Growth Factor beta1 / Q000494:pharmacology; D014599:Uterus / Q000166:cytology*
D017077:Culture Media, Conditioned; D016207:Cytokines; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D008024:Ligands; D012333:RNA, Messenger; D051193:Toll-Like Receptors; D053773:Transforming Growth Factor beta1
Annu Rev Immunol. 2003;21:685-711
12615891
J Immunol. 2000 Apr 1;164(7):3596-9
10725715
J Immunol. 2006 Dec 15;177(12):8550-9
17142753
Semin Immunol. 2005 Aug;17(4):251-2
15955711
Gastroenterology. 2004 Jul;127(1):300-9
15236195
J Exp Med. 1994 Apr 1;179(4):1109-18
8145033
Biol Reprod. 1995 Sep;53(3):488-98
7578671
Mol Immunol. 2006 Jul;43(14):2151-60
16490253
J Immunol. 2001 Jan 1;166(1):249-55
11123299
Transfusion. 2006 Dec;46(12):2083-9
17176319
Am J Pathol. 1987 Apr;127(1):66-73
3565538
J Biol Chem. 1988 Feb 5;263(4):2041-8
3123485
Biochem Biophys Res Commun. 2003 Jul 4;306(3):674-9
12810071
Blood. 2006 Sep 1;108(5):1435-40
16684955
Eur J Immunol. 2008 Jun;38(6):1689-99
18421791
Am J Reprod Immunol. 2005 Oct;54(4):193-202
16135010
Hum Reprod. 2008 Jul;23(7):1574-80
18285323
Nat Med. 2005 Apr;11(4 Suppl):S45-53
15812489
J Immunol. 2008 May 1;180(9):5771-7
18424693
Nat Immunol. 2001 Aug;2(8):725-31
11477409
J Immunol. 1997 Mar 15;158(6):3017-27
9058841
Immunobiology. 2004;209(1-2):191-8
15481153
J Immunol. 2005 Aug 1;175(3):1609-18
16034100
Mol Hum Reprod. 2005 Nov;11(11):801-8
16403803
Annu Rev Immunol. 2007;25:381-418
17378762
Nat Immunol. 2005 May;6(5):507-14
15821737
Curr Opin Immunol. 2004 Jun;16(3):321-7
15134781
Blood. 1997 Sep 1;90(5):1920-6
9292525
Microbes Infect. 1999 Nov;1(13):1079-84
10572310
Hum Reprod. 2005 Jun;20(6):1439-46
15734755
J Cell Biol. 2008 Sep 8;182(5):993-1005
18762577
Eur J Immunol. 2006 Apr;36(4):864-74
16544275
J Immunol. 2006 Dec 1;177(11):7959-67
17114468
Trends Immunol. 2002 Sep;23(9):445-9
12200066
J Immunol. 2005 Feb 15;174(4):2061-70
15699136
J Immunol. 2005 Jan 15;174(2):992-1002
15634923
J Soc Gynecol Investig. 2004 Oct;11(7):488-93
15458747
Nat Rev Immunol. 2008 Dec;8(12):935-47
19029989
J Clin Immunol. 2005 May;25(3):177-88
16118915
Nat Rev Immunol. 2006 Jun;6(6):476-83
16691244
J Immunol. 2007 Feb 15;178(4):1986-90
17277101
Nat Rev Immunol. 2004 Oct;4(10):762-74
15459668
Am J Reprod Immunol. 2005 Apr;53(4):199-205
15760381
J Reprod Immunol. 1998 Oct;40(1):25-45
9862255
Mol Pharmacol. 2002 Jul;62(1):65-74
12065756
Endocrinology. 1994 Jul;135(1):439-49
8013382
Rev Reprod. 1998 Jan;3(1):1-6
9509983
Science. 2004 Aug 20;305(5687):1153-7
15326355
Adv Immunol. 1994;55:97-179
8304236
J Immunol. 2005 Aug 1;175(3):1373-81
16034072
Curr Opin Immunol. 2007 Feb;19(1):73-8
17142025
Biol Reprod. 2006 Sep;75(3):387-94
16707768
Mucosal Immunol. 2008 Nov;1(6):451-9
19079212
Immunobiology. 2004;209(7):569-74
15568621
Nat Rev Immunol. 2007 Aug;7(8):610-21
17627284
Immunity. 2008 Sep 19;29(3):362-71
18799144
Annu Rev Immunol. 2006;24:99-146
16551245
Blood. 2009 Jul 16;114(3):555-63
19465693
Adv Immunol. 1998;70:83-243
9755338
Immunology. 2004 Jul;112(3):428-36
15196211